Source comparison
A Comparison of Neuro-Regenerative Peptides
To provide a clearer picture, our team put together a brief comparison of several peptides often discussed in the context of neurological research. This helps illustrate where BPC-157 fits into the broader landscape. Keep in mind, this is for informational pur
This comparison does not assign a generated winner or score.
- To provide a clearer picture, our team put together a brief comparison of several peptides often discussed in the context of neurological research. This helps illustrate where BPC-157 fits into the broader landscape. Keep in mind, this is for informational purposes in a research context.
- BPC-157
- Angiogenesis (VEGF pathway), axonal outgrowth, modulation of nitric oxide.
- Gut health, soft tissue repair, peripheral and central nerve injury.
- Injectable, Oral Capsules
- TB-500 (Thymosin Beta-4)
- Promotes cell migration (actin upregulation), anti-inflammatory, angiogenesis.
- Wound healing, cardiac repair, soft tissue recovery, synergistic nerve repair.
- Injectable
- Cerebrolysin
- Neurotrophic factor mimicry, protects neurons from excitotoxicity.
- Stroke recovery, traumatic brain injury, dementia models.
- ARA-290
- Targets the innate repair receptor (IRR), powerfully anti-inflammatory.
- Neuropathic pain, autoimmune conditions, neuroinflammation.
- As you can see, while there's some overlap (like angiogenesis), each compound has a distinct primary strength. This is why combination research, such as studying BPC-157 alongside TB-500 (a core component of our popular Wolverine Peptide Stack), is becoming increasingly common. The hypothesis is that their different mechanisms could offer a powerful synergistic effect.